Clinical trial
A Clinical Investigation of MINIVISC® PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC)
NCT07184437 is registered in ClinicalTrials.gov with Bohus Biotech AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Investigation of MINIVISC® PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC)
- Lead sponsor
- Bohus Biotech AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 20, 2024
- Completion date
- July 29, 2025
- Enrollment
- 134 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.